期刊文献+

NOD小鼠糖尿病早期Th1细胞与CD4^+CD25^+Treg细胞的变化 被引量:3

Changes in Th1 cells and CD4^+CD25^+Treg cells in non-obese diabetic mice at early stage of diabetes
暂未订购
导出
摘要 目的研究Th1细胞和CD4+CD25+Treg细胞在NOD小鼠糖尿病早期的变化,并评价其作用。方法选择4周(A组)、8周(B组)和16周龄(C组)的雌性NOD小鼠,取脾、胸腺和胰腺组织,采用流式细胞术测定脾Th1和CD4+CD25+Treg细胞的比例,计算Th1/CD4+T、CD4+CD25+Treg/CD4+T和Th1/CD4+CD25+Treg的比值,再测定胸腺CD4–CD8–T、CD4+CD8+T、CD4–CD8+T和CD4+CD8–T细胞比例,计算CD25+Treg/CD4+CD8–T的比值。取胰腺组织,行HE染色和Foxp3免疫组化染色,观察胰腺病理学变化。结果 C组小鼠脾脏Th1细胞比例以及Th1/CD4+T和Th1/CD4+CD25+Treg比值明显高于A组和B组,但是A、B、C三组脾脏CD4+CD25+Treg细胞比例及CD4+CD25+Treg/CD4+T比值差异无统计学意义。三组间胸腺CD4–CD8–T、CD4+CD8+T、CD4–CD8+T和CD4+CD8–T细胞比例差异无统计学意义,但是B组和C组胸腺CD25+Treg/CD4+CD8–T比值明显高于A组。HE染色结果显示,B组和C组的胰岛周围可见淋巴细胞浸润,但胰岛周围淋巴细胞浸润部位免疫组化染色未见Foxp3阳性细胞。结论 NOD小鼠糖尿病早期外周Th1细胞呈进行性增加,但CD4+CD25+Treg细胞相对缺乏,考虑与NOD小鼠糖尿病进展有关。 Objective To investigate the changes in Thl cells and CD4+CD25+Treg cells in non-obese diabetic (NOD) mice at early stage of diabetes, and to evaluate the significance of these changes. Methods Four week- (group A), 8 week- (group B) and 16 week-old (group C) female NOD mice (8 each) were used in present study. The spleen, thymus and pancreas were harvested. Thl and CD4+CD25+Treg cells in spleen were determined by flow cytometer, and the ratios of Thl/CD4+T, CD4+CD25+Treg/ CD4+T and Th1/CD4+CD25+Treg were calculated. Subsequently, CD4-CDKT, CD4+CD8+T, CD4 CD8+T and CD4+CD8 T cells in thymus were determined by flow cytometer, and the ratio of CD25+Treg/CD4+CD8-T was calculated. The histopathological changes in pancreas were also evaluated by HE staining and immunohistochemistry staining. Results The proportion of Thl cells in spleen and the ratios of Thl/CD4+T and Thl/CD4+CD25+Treg were higher significantly in group C than in group A and B. However, no significant differences were found in the proportion of spleen CD4+CD25+Treg cells and the ratio of CD4+CD25+Treg/CD4+T among the three groups. Compared with group A, no obvious changes were found in thymus CD4 CD8-T, CD4+CD8+T, CD4 CD8+T and CD4+CD8 T cells in group B and C, but the ratio of thymus CD25+Treg/CD4+CD8-T increased significantly in group B and C. Lymphocytic infiltration was observed in pancreatic islets of group B and C as shown with HE staining, but Foxp3+T cells were not seen in pancreatic islets by immunohistochemistry. Conclusion Thl cells are gradually increased at early stage of diabetes in NOD mice, but CD4+CD25+Treg cells are relatively default. These changes may play an important role in the progress of diabetes.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2013年第11期888-891,共4页 Medical Journal of Chinese People's Liberation Army
基金 吉林省教育厅"十一五"科学技术研究项目(2008401) 吉林省科技发展计划项目(20130101140JC)~~
关键词 小鼠 近交NOD TH1细胞 CD4+CD25+调节性T细胞 糖尿病 1型 mice, inbred NOD Thl cells CD4+CD25+Treg cells diabetes mellitus, type 1
  • 相关文献

参考文献14

  • 1Santamaria P. The long and winding road to understanding and conquering type 1 diabetes[J]. Immunity, 2010, 32(4): 437-448.
  • 2Bluestone JA, Tang Oj Sedwick CE. T regulatory cells in autoimmune diabetes: past challenges, future prospects[J]. J Clin Immunol, 2008, 28(6): 677-684.
  • 3Feuerer M, Shen Y, Littman DR, et al. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets [J]. Immunity, 2009, 31 (4): 654-664.
  • 4张梅,徐书杭,茅晓东,刘翠萍,刘超.NOD小鼠自然状态下CD4^+CD25^+T细胞的动态变化及意义[J].现代免疫学,2008,28(6):479-482. 被引量:2
  • 5李卫鹏,申勇,胡永全,史桂英,王福庆.NOD小鼠CD4^+CD25^+调节性T细胞功能变化研究[J].蚌埠医学院学报,2008,33(6):743-746. 被引量:2
  • 6支涤静,王晓川,沈水仙,罗飞宏,苏贻新,方昕,唐林妹.儿童1型糖尿病T_H1/T_H2免疫应答状况研究[J].中华儿科杂志,2001,39(3):148-150. 被引量:6
  • 7Cnop M, Welsh N, Jonas JC, et al. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities[J]. Diabetes, 200S, S4(Suppl 2): S97-S107.
  • 8Brusko TM, Wasserfall CH, Clare-Salzler MJ, et al. Functional defects and the influence of age on the frequency of CD4^+CD25^+T cells in type 1 diabetes [J]. Diabetes, 2005, 54(5): 1407-1414.
  • 9Tang Oa Adams JY, Penaranda C, et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction[J]. Immunity, 2008, 28(5): 687-697.
  • 10Zhou X, Bailey-Bucktrout SL, Jeker LT, et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo[J]. Nat Immunol, 2009, 10(9): 1000- 1007.

二级参考文献16

  • 1李卫鹏,王福庆.CD4^+CD25^+ Treg的免疫调节作用机制以及临床研究进展[J].现代免疫学,2006,26(2):164-167. 被引量:18
  • 2杨滨燕,沈二霞,吴长有.小鼠脾细胞CD4^+ CD25^+调节性T细胞的表型特征[J].现代免疫学,2006,26(3):208-212. 被引量:4
  • 3Sakaguchi S, Sakaguehi N, Asano M, et al. Immunologic self- tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains ( CD25 ). Breakdown of a single mechanism of self- tolerance causes various autoimmune diseases [ J]. J Immunol, 1995,155(3) :1 151 -1 564.
  • 4Banham AH. Cell-surface IL-7 receptor expression facilitates the purification of FOXP3 ( + ) regulatory T cells [ J ]. Trends Immunol,2006,27 ( 12 ) :541 - 544.
  • 5Bruder D,Probst-Kepper M,Westendorf AM, et al. Neuropilin-1 : a surface marker of regulatory T cells[ J]. Eur J Immunol,2004, 34 (3) :623 - 630.
  • 6Fehervari Z, Sakaguchi S. Development and function of CD25^+ CD4^+ regulatory T cells [ J ]. Curr Opin Immunol, 2004,16 ( 2 ) : 203 - 208.
  • 7Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4^+ CD25^+ regulatory T cells[J]. Nat Immunol,2003 ,4( 4 ) :330 -336.
  • 8Khattri R, Cox T, Yasayko SA, et al. An essential role for Scurfin in CD4^+CD2^+ T regulatory cells4 [ J ]. Nat Immunol, 2003,4 (4) :337 -342.
  • 9Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3 [ J ]. Science,2003, 14 299(5 609) :1 057 -1 061.
  • 10Ono M, Yaguchi H, Ohkura N,et al. Foxp3 controls regulatory T- cell function by interacting with AML1/Runx1 [ J ]. Nature,2007, 446(7 136) :685 -689.

共引文献7

同被引文献31

  • 1张梅,徐书杭,茅晓东,刘翠萍,刘超.NOD小鼠自然状态下CD4^+CD25^+T细胞的动态变化及意义[J].现代免疫学,2008,28(6):479-482. 被引量:2
  • 2苑瑞琴.290例血液标本不合格原因分析及对策[J].临床输血与检验,2011,13(2):175-176. 被引量:27
  • 3涂学亮,王坤,李玲,戴鲁琼.临床生物化学检验标本的采集与处理[J].检验医学与临床,2007,4(6):552-553. 被引量:11
  • 4杜强,贾丽艳.SPSS统计分析[M].北京:人民邮电出版社,2009,419-420.
  • 5刘丽群,廖有乔.2型糖尿病患者IL-15水平检测及其临床意义[J].临床内科杂志,2007,24(8):571-572. 被引量:1
  • 6Quinn Lebris S, Strait-Bodey Lena,Anderson Barbara G, et al. Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes: evidence for a skeletal muscle-to-fat signaling pathway [ J ]. Cell Biol Int,2005,29 ( 6 ) : 449.
  • 7Almendro V, Busquets S, Ametller E, et al. Effects of interleukin-15 on lipid oxidation: disposal of an oral [ (14) C ] -triolein load [ J ]. Biochim Biophys Acta, 2006,1761 (1) :37.
  • 8Huang-Pin Wu, Sheng-Fong Kuo, Shao-Yun Wu, et al. High interleukin-12 production from stimulated peripheral blood mononuclear cells of type 2 diabetes patients[ J]. Cytokine ,2010,51 (3) :298.
  • 9Mishra Manish, Kumar Hemant, Bajpai Surabhi,et al. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes [ J ]. Diabetes Res Clin Praet, 2011, 94 (2) :255.
  • 10Gverovi C Antuniea A, Karaman K, Znaor L, et al. IL-12 concentrations in the aqueous humor and serum of diabetic retinopathy patients [ J ]. Graefes Arch Clin Exp Ophthalmol, 2012,250 ( 6 ) : 815.

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部